Acquisition Creates Global Leader in Community-Based Software Solutions
Accelerates ResMed’s SaaS strategy by expanding ResMed’s position as the leading US provider of SaaS solutions to out-of-hospital care facilities in Germany
MEDIFOX DAN will integrate with ResMed’s non-hospital SaaS business segment, expanding its solution portfolio to new healthcare sectors, including outpatient therapy
Purchase price of approximately US$1 billion
At closing, the acquisition is expected to be accretive to ResMed’s non-GAAP diluted earnings per share
SAN DIEGO and HILDESHEIM, Germany, June 14, 2022 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German leader in out-of-hospital software solutions for providers in key settings across the continuum of care, from Hg, a major investor in software and services.
MEDIFOX DAN’s clinical, financial and operational solutions are essential for out-of-hospital care providers, including care documentation, staff scheduling, administration, billing, and more. – similar to the solutions of the main American SaaS brands of ResMed, MatrixCare and Brighttree.
MEDIFOX DAN’s German customer base is complementary to customers of ResMed’s US-based SaaS business. Additionally, the acquisition of MEDIFOX DAN builds on ResMed’s existing business in Germany as a leading provider of innovative cloud-connected medical devices that are transforming care for patients with sleep apnea and other respiratory conditions. .
Under the leadership of co-CEOs Dr. Thorsten Schliebe and Christian Städtler, the MEDIFOX DAN Group has continuously expanded its portfolio of innovative products and services, advanced into new market segments, invested in a state-of-the-art system landscape and digital capabilities sales and made strategic acquisitions. With the market launch of the new generations of MD Outpatient and MD Inpatient software, MEDIFOX DAN is setting new standards for the future of care and is set to accelerate the digitalization of healthcare within the global ResMed team. It is now important to join forces and use synergies to revolutionize the digitization of healthcare with combined forces.
“With the acquisition of MEDIFOX DAN, an innovative and fast-growing German healthcare software leader, we will expand ResMed’s portfolio of SaaS businesses outside of our current base in the US market and strengthen our position as a global leader in lower-cost healthcare software solutions and lower-acuity care,” said Mick Farrell, CEO of ResMed. “We are delighted to welcome the MEDIFOX DAN team to our global ResMed family: our management cultures are strongly aligned on a laser focus on reducing costs, improving outcomes and changing the course of chronic disease management MEDIFOX DAN has a strong track record of innovation, fully aligned with our teams at Brightree, MatrixCare and at MEDIFOX DAN’s customer focus has created continued strong demand for its software solutions throughout Germany, and we expect this momentum to continue. Follows and grows stronger as we become a global team. Our MEDIFOX DAN and ResMed teams are united with the same global mission: to help hundreds of millions of people live healthier lives outside of the hospital, and preferably at home.
“I am thrilled with this historic union between ResMed and MEDIFOX DAN, and the tremendous opportunities it opens up for thousands of providers and millions of patients,” said Bobby Ghoshal, president of ResMed SaaS. “We are seeing greater adoption of digital solutions across Germany as its population continues to age and severe staffing shortages continue to challenge German healthcare providers. MEDIFOX DAN – and ResMed – are well positioned to help providers in leading community care facilities meet growing demands and ultimately improve patient outcomes.
“MEDIFOX DAN helps people to help people. We believe that the partnership with ResMed is a unique opportunity to deliver on this promise through the strategic outlook of an international player on an even larger scale in the future. Now we are part of a specialized in the digitization of the healthcare system. A major advantage of this transaction is the wide range of possibilities for an incredibly agile combination of a wide variety of services, which our customers will particularly benefit from in their daily care work. We look forward to taking this next development step together and continuing to support our customers in their daily work with innovative software solutions and services in the best possible way,” said the co-CEOs of MEDIFOX DAN, the Dr. Thorsten Schliebe and Christian Städtler.
Stefan Margolis and Benedikt Joeris, both partners at Hg, said: “It has been a great journey and partnership with Thorsten, Christian and the entire MEDIFOX DAN team. MEDIFOX DAN has long been recognized as a high quality software company, providing essential services to integrated care. Together, we have significantly expanded the MEDIFOX DAN offering through continued product investment and acquisitions. ResMed, which we have known for many years, will be a great strategic owner to continue this journey of innovation, allowing caregivers to focus on people and patients.
MEDIFOX DAN is headquartered in Hildesheim, Germany, and employs over 600 people. ResMed expects MEDIFOX DAN to operate under its current brand within the ResMed SaaS business – like Brightree and MatrixCare do today.
Under the terms of the agreement, ResMed will acquire MEDIFOX DAN for approximately US$1.0 billion (€950 million), which ResMed expects to fund with its existing credit facilities. In calendar year 2021, MEDIFOX DAN’s pro forma net revenue was approximately $83 million, with pro forma adjusted EBITDA of approximately $35 million.
The transaction is expected to be accretive to ResMed’s non-GAAP diluted earnings per share after closing.
The transaction is expected to close by the end of ResMed’s second quarter of fiscal year 2023 (December 31, 2022), subject to regulatory approvals.
ResMed intends to retain the employees, management structure, sites and business processes of MEDIFOX DAN. MEDIFOX DAN Co-Chief Executive Officers Dr. Thorsten Schliebe and Christian Städtler will continue in their current roles and report to ResMed SaaS President Bobby Ghoshal.
Evercore is ResMed’s financial advisor and DLA Piper is ResMed’s legal advisor.
Webcast for investors
ResMed will discuss the transaction during a live webcast at 11:00 a.m. Eastern Time on June 14, 2022. The live webcast can be accessed on ResMed’s Investor Relations website at investor .resmed.com. The online archive of the broadcast will be available on the ResMed website approximately two hours after the broadcast. Additionally, a telephone replay of the webcast will be available approximately two hours after the call by dialing +1 877.660.6853 (US) and +1 201.612.7415 (international) and entering the confirmation number from event 13730641. The phone replay will be available until June 28, 2022.
At ResMed (NYSE: RMD, ASX: RMD), we pioneer innovative solutions that treat and keep people out of hospital, enabling them to live healthier, higher quality lives. Our digital health technologies and cloud-connected medical devices are transforming care for people with sleep apnea, COPD and other chronic conditions. Our comprehensive out-of-hospital software platforms support professionals and caregivers who help people stay healthy at home or in the care setting of their choice. By enabling better care, we are improving quality of life, reducing the impact of chronic disease and reducing costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
About MEDIFOX DAN
The MEDIFOX DAN Group, headquartered in Hildesheim, Germany, currently employs over 600 people at nine locations nationwide and specializes in the development of innovative software solutions and services for professional and non-professional care, therapeutic practices and child, family and youth protection institutions. . In addition, digital solutions for modern training and education management – both for professional care and family carers – expand the group’s comprehensive product portfolio. What started as a small start-up has grown into an established software company. Besides holistic product solutions, MEDIFOX DAN has always been characterized by strong partnerships and innovative services. Behind MEDIFOX DAN is a team of innovative minds, with over 55 years of industry experience and cumulative expertise, who work every day to set forward-thinking standards for digitization in healthcare. and social services and to advance innovation. In short: we are more than just software.
Statements in this press release that are not historical facts are “forward-looking” statements as contemplated by the Private Securities Litigation Reform Act of 1995. These forward-looking statements – including statements regarding ResMed’s projections regarding future revenues or profits, expenses, new product development, new product launches and new markets for its products and the integration of acquisitions – are subject to risks and uncertainties that could cause that actual results differ materially from those projected or implied by the forward-looking statements. Additional risks and uncertainties are discussed in ResMed’s periodic reports filed with the United States Securities & Exchange Commission. ResMed does not undertake to update its forward-looking statements.